These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6735039)

  • 1. [Systemic circulatory hyperkinetic syndrome in patients with cirrhosis. Relation with hepatocellular failure and portal hypertension].
    Valla D; Poynard T; Bercoff E; Bataille C; Goldfarb G; Lebrec D
    Gastroenterol Clin Biol; 1984 Apr; 8(4):321-4. PubMed ID: 6735039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome.
    Blei AT; Mazhar S; Davidson CJ; Flamm SL; Abecassis M; Gheorghiade M
    J Clin Gastroenterol; 2007; 41 Suppl 3():S323-9. PubMed ID: 17975484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
    Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD
    Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension.
    Vlavianos P; Mac Mathuna P; Williams R; Westaby D
    Clin Sci (Lond); 1999 May; 96(5):475-81. PubMed ID: 10209079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac involvement in liver cirrhosis.
    Gatta A; Merkel C; Sacerdoti D; Angeli P
    Ann Ital Med Int; 1993; 8(4):244-7. PubMed ID: 8161481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of clinical findings in evaluating the degree of portal hypertension in patients with liver cirrhosis].
    Jedlicka J; Petrtýl J; Tesar V; Marecek Z; Cervinka J; Kordac V
    Cas Lek Cesk; 1989 Aug; 128(33):1035-9. PubMed ID: 2790908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
    Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splanchnic hemodynamic factors in cirrhosis with refractory ascites.
    Lebrec D; Kotelanski B; Cohn JN
    J Lab Clin Med; 1979 Feb; 93(2):301-9. PubMed ID: 429841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver cirrhosis and cardiovascular system].
    Ponte E; Cafagna D
    Minerva Med; 1996 Jun; 87(6):299-310. PubMed ID: 8700359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation between plasma catecholamines, the severity of the liver disease and hemodynamics in patients with cirrhosis].
    Gaudin C; Braillon A; Moreau R; Roulot D; Bacq Y; Hadengue A; Lebrec D
    Gastroenterol Clin Biol; 1989; 13(8-9):701-6. PubMed ID: 2680727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in systemic and splanchnic hemodynamics after orthotopic liver transplantation in cirrhotic rats.
    Cao H; Wu Z; Zhang X; Zhang H; Chen Z; Kuang Y
    Chin Med J (Engl); 2000 Dec; 113(12):1108-11. PubMed ID: 11776147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of anemia on hemodynamic changes in patients with cirrhosis].
    Denié C; Poynard T; Gadano A; Vachiery F; Soupison T; Elman A; Valla D; Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1997; 21(1):29-33. PubMed ID: 9091387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC; Lin HC; Yang YY; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 2001 Apr; 96(4):1210-6. PubMed ID: 11316172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
    Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic alterations in liver cirrhosis.
    La Villa G; Gentilini P
    Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of rectal mucosal hemodynamics in patients with liver cirrhosis using reflectance spectrophotometry.
    Tezuka T; Akita Y; Yoshikawa N; Mitamura K
    Am J Gastroenterol; 1997 Jun; 92(6):1022-5. PubMed ID: 9177523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.